Atara Biotherapeutics所有資訊

Atara Biotherapeutics | DEFA14A：其他

04/26 16:25 (美東)

Atara Biotherapeutics | DEF 14A：股東委託書決議

04/26 16:21 (美東)

Atara Biotherapeutics | PRE 14A：並購重組委托聲明

04/12 16:19 (美東)

Atara Biotherapeutics | 4：持股變動聲明-董事 Fust Matthew K

04/02 18:16 (美東)

Atara Biotherapeutics | 4：持股變動聲明-董事 HEIDEN WILLIAM K

04/02 18:15 (美東)

Atara Biotherapeutics | 4：持股變動聲明-董事 Roncarolo Maria Grazia

04/02 18:15 (美東)

Atara Biotherapeutics | 4：持股變動聲明-董事 Gallagher Carol Giltner

04/02 18:15 (美東)

Atara Biotherapeutics | 4：持股變動聲明-董事 MALLIK AMEET

04/02 18:15 (美東)

Atara Biotherapeutics | 8-K：重大事件

03/29 16:33 (美東)

Atara Biotherapeutics | 10-K：年度報表

03/28 08:44 (美東)

Atara Biotherapeutics | 8-K：Atara Biotherapeutics公佈2023年第四季度和全年財務業績和運營進展

03/28 08:39 (美東)

Atara Biotherapeutics | SC 13G：超過5%持股股東披露文件-Citadel Advisors LLC(6.4%),Citadel Advisors Holdings LP(6.4%)等

03/18 16:16 (美東)

Atara Biotherapeutics | 4：持股變動聲明-高管 Touchon Pascal

03/06 18:48 (美東)

Atara Biotherapeutics | 4：持股變動聲明-高管 Nguyen AnhCo

03/06 18:48 (美東)

Atara Biotherapeutics | 4：持股變動聲明-高管 Murugan Amar

03/06 18:48 (美東)

Atara Biotherapeutics | 4：持股變動聲明-高管 Hyllengren Eric J

03/06 18:48 (美東)

Atara Biotherapeutics | 4：持股變動聲明-高管 Henrich Jill

03/06 18:48 (美東)

Atara Biotherapeutics | 144：擬議出售證券

03/04 20:21 (美東)

Atara Biotherapeutics | 144：擬議出售證券

03/04 20:21 (美東)

Atara Biotherapeutics | 144：擬議出售證券

03/04 20:21 (美東)